2 recruiting. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 2 |
| Phase 1 | 1 | Recruiting 1 |
Follow Timolol eye drops 0.5%: new trials by email Literature Review of Timolol eye drops 0.5% trials Research Report on Timolol eye drops 0.5%
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of TimoD Sustained-Release Implant in Participants With Glaucoma or Ocular Hypertension Undergoing Cataract Surgery TimoD implant, Injector system, Timolol eye drops 0.5% - Glaucoma, Ocular Hypertension | Phase 1 / Phase 2 | Recruiting | EyeD Pharma | 42 | 2025-06-12 | 2026-07-30 |
| Phase 2 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant Gen 2 Travoprost Intracameral Implant, Timolol eye drops 0.5%, Sham Procedure - Glaucoma | Phase 2 | Recruiting | Glaukos Corporation | 110 | 2025-06-12 | 2026-09-17 |
Glaucoma (2) · Ocular Hypertension (2) · Cataract (1) · Glaucoma, Open-Angle (1) · Lens Diseases (1)
EyeD Pharma (1) · Glaukos Corporation (1)
Panama (1) · United States (1)